ADMA Biologics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2830 www.admabiologics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics, Inc.

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Feb 12th, 2026 3:45 pm
Assessing ADMA Biologics (ADMA) Valuation After Growing Analyst Optimism On Earnings And Plasma Therapy Pipeline - Feb 5th, 2026 5:16 am
Is ADMA Biologics (ADMA) Pricing Reflect A Potential Gap To DCF And P/E Estimates - Feb 5th, 2026 2:18 am
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Feb 2nd, 2026 3:50 pm
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - Jan 29th, 2026 7:30 am
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know - Jan 26th, 2026 3:50 pm
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Jan 22nd, 2026 7:13 am
High Growth US Tech Stocks To Watch In January 2026 - Jan 21st, 2026 4:38 am
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know - Jan 20th, 2026 4:00 pm
ADMA Biologics, Inc. (ADMA): A Bull Case Theory - Jan 14th, 2026 6:36 am
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Jan 13th, 2026 3:50 pm
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook - Jan 13th, 2026 11:28 am
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - Jan 13th, 2026 7:30 am
How ADMA’s Multi‑Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story - Jan 12th, 2026 9:25 pm
A Look At ADMA Biologics (ADMA) Valuation After Raised Guidance And New Long Term Growth Targets - Jan 12th, 2026 3:09 pm
ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference - Jan 12th, 2026 11:47 am
Is ADMA Biologics (ADMA) Still Attractive After Recent Share Price Pullback - Jan 12th, 2026 11:09 am
ADMA Biologics Updates 2025, 2026 Revenue Outlook; 2027 Guidance Issued - Jan 12th, 2026 6:57 am
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update - Jan 12th, 2026 6:00 am
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Jan 6th, 2026 3:50 pm